Recent Articles from GlobeNewswire

SUMMARY: As part of its Impact in Five fifth anniversary celebrations, Beyond Green mobilized its global community through a coordinated Global Cleanup initiative in recognition of World Cleanup Day and National Cleanup Month. Member hotels and associates across three continents led local cleanups and environmental stewardship activities, demonstrating the brand's commitment to placing purpose and responsibility at the heart of travel.

In a porcine model of severe acute alcohol intoxication, GOA26 demonstrated a rapid reduction in blood alcohol concentration and multi-system biochemical recovery across metabolic, muscle, hematological and liver biomarkers.

Transaction supports Gevo's path toward a carbon business exceeding $30 million in annual revenue from existing operations

Multi-year $2 billion agreement will expand capacity for advanced packaging ecosystem and support growing demand for AI and high-performance computing technologies

Transaction in Own Shares

Lindquist claims a $10,000 seat in the World Series of Golf Championship, presented by Lotto.com, after taking a three-way all-in pot on the eighth hole

Ground Truth is a 5-layer suite built on Safe Pro’s AI models that processed 3.1+ million drone images with 58,526 confirmed threat detections and mapped 39,777+ acres in Ukraine

Banks and credit unions can set their own liquidity, approval, and compliance rules for instant payments, around the clock

HOUSTON, Oct. 08, 2026 (GLOBE NEWSWIRE) -- HyOrc Corporation (OTCQB: HYOR) today reported strong industry engagement following the Company's presentation at the Dow Jones: OPIS World Methanol Conference in Rotterdam, where CEO Reginald Fubara presented HyOrc's waste-to-methanol technology and commercial deployment strategy.

Using multiple vendors across Kratos’ OpenSpace’s fully virtualized platform proves that space can support terrestrial-level interoperability and scale

VANCOUVER, British Columbia, Oct. 08, 2026 (GLOBE NEWSWIRE) -- NOVAGOLD RESOURCES INC. (“NOVAGOLD” or the “Company”) (NYSE American, TSX: NG) today filed its 2026 third quarter report and provided an update on its Tier One1 gold development project held by Donlin Gold LLC (“Donlin Gold”), which is owned 60% by NOVAGOLD through NOVAGOLD Resources Alaska, Inc., a wholly-owned subsidiary of the Company, and 40% by Paulson Advisers LLC and certain of its affiliates (collectively “Paulson”) through Donlin Gold Holdings LLC (“Donlin Gold Holdings”).

Brings more than 25 years of experience in clinical strategy, biostatistics and regulatory submissions from Abivax, Alumis, MyoKardia and Genentech/Roche

NEW YORK, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Satellogic Inc. (NASDAQ: SATL), the infrastructure company for Persistent Global Intelligence (PGI), today announced that Satellogic's Interim CFO & SVP, Corporate Controller, Dustin Greer, and Chief of Staff, Dr. Caitlin Kontgis, will host an in-person presentation and one-on-one meetings with investors at the LD Micro 20th Annual Main Event, being held October 20-21, 2026 at the Luxe Sunset Blvd. Hotel in Los Angeles.

HOUSTON, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Tokio Marine HCC (TMHCC), based in Houston, Texas, today announced a $100 million commitment as a seed investor to a new emerging markets fund. The fund, established by International Finance Corporation (IFC), a member of the World Bank Group, is managed by BlueOrchard Finance Ltd. Tokio Marine & Nichido Fire Insurance Co., Ltd. (TMNF) has committed a further $200 million, taking Tokio Marine Group's total anchor commitment to $300 million.

Financing will support market expansion, expand access, and advance the clinical evidence needed to broaden the role of robotic microsurgery

Conference Call to be held Wednesday, October 28, 2026, at 8:00 a.m. Central Time

Latest award expands OSS’s role in a next-generation platform for mission-critical electronic warfare simulation

Joint offering combines XBP’s Smart Office suite, CXAI’s employee experience platform, and Macro Group’s facilities management expertise; showcased at “The Future of Work” event in New York

FLORHAM PARK, N.J., Oct. 08, 2026 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, today announced its participation in the American College of Gastroenterology (ACG) 2026 Annual Scientific Meeting, being held October 9-14 in Nashville, Tennessee.

Board seat at Europe’s chemical recycling industry association comes as EU regulatory framework for circular plastics takes shape and Aduro advances its FOAK Plant at Chemelot, the Netherlands

Two-day conference features keynotes, customer showcases, hands-on masterclasses, and industry tracks for Healthcare and for Banking, Financial Services & Insurance

SAN MATEO, Calif., Oct. 08, 2026 (GLOBE NEWSWIRE) -- Freshworks Inc. (NASDAQ: FRSH) will announce its financial results for the third quarter ended September 30, 2026 following the close of market on Tuesday, November 3, 2026. Freshworks will host a live audio webcast beginning at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time that same day to discuss the company’s financial results and business highlights.

UCHealth is among the first transplant centers in the western U.S. using OrganOx

MOUNTAIN VIEW, Calif., Oct. 08, 2026 (GLOBE NEWSWIRE) -- Spirair, Inc., a medical technology company advancing next-generation solutions for ear, nose, and throat care, today announced publication of six-month results from the Vayu Study of SeptAlign®, the company’s FDA-cleared bioresorbable implant for minimally invasive correction of cartilaginous nasal septal deviation. The manuscript, “Safety and Effectiveness of a Bioabsorbable Septal Implant for Cartilaginous Nasal Septal Deviation,” appears in Laryngoscope Investigative Otolaryngology.

MIAMI, Oct. 08, 2026 (GLOBE NEWSWIRE) -- UMeWorld Inc. (OTCQB: UMEW) (“UMeWorld” or the “Company”) today announced that its common stock has been approved for trading on the OTCQB Venture Market, effective October 8, 2026. The Company also announced that it has entered into an engagement agreement with ARC Group Securities, LLC (“ARC”) to support a proposed uplisting to the Nasdaq Capital Market and an associated capital raising initiative.

Stuart Job joins CTR after a decade-plus at Shell

Launch expands ROC’s commercial growth strategy, delivers NIST-ranked facial age estimation via enterprise API

TEL AVIV, Israel, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX) (“Entera” or the “Company”), a leader in the development of oral peptides, today announced that an additional presentation highlighting the clinical study design for its planned Phase 3 registrational trial of EB613 (oral PTH(1-34) tablet) will be presented at the American Society for Bone and Mineral Research (ASBMR) 2026 Annual Meeting, taking place October 9-12, 2026, at the John B. Hynes Veterans Memorial Convention Center in Boston, Massachusetts.

MANCHESTER, N.H., Oct. 08, 2026 (GLOBE NEWSWIRE) -- Allegro MicroSystems, Inc. (Nasdaq: ALGM) today announced it plans to release financial results for its second quarter fiscal year 2027 prior to the market open on Thursday, October 29, 2026. Following the press release, Mike Doogue, President and Chief Executive Officer, and Derek D’Antilio, Executive Vice President and Chief Financial Officer, will host a conference call at 8:30 a.m. Eastern Time to discuss the Company’s results and business outlook.

Company puts ATM program in place to provide flexible financing and support disciplined capital management

Real user reviews highlight Veriff's fast, AI-driven identity and proof-of-address verification, global document coverage, and ease of doing business.

BRIDGEWATER, N.J., Oct. 08, 2026 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) (“Amneal” or the “Company”), today announced it will report third quarter 2026 financial results on Tuesday, November 3, 2026, before market open. The Company will host an audio webcast at 8:30 a.m. ET.

1 keV result announced jointly with the UKAEA and accompanied by meaningful ion heating

The leading waxing franchise continues its category dominance, earning the top spot for the fifth consecutive year

AUSTIN, Texas, Oct. 08, 2026 (GLOBE NEWSWIRE) -- via IBN – IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest episode of The Stock2Me Podcast as part of its sustained effort to provide specialized content distribution via widespread syndication channels.

LIBERTY CORNER, N.J., Oct. 08, 2026 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company, today announced that the United States Patent and Trademark Office (“USPTO”) has granted a new Method of Use patent for certepetide [U.S. Patent No. 12,751,991] for the treatment of pancreatic cancer and other solid tumors, expiring May 2041.

TORONTO, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, today announced that the United States District Court for the Southern District of New York has agreed to consolidate both the Company’s direct action and a class action led by an individual investor alleging market manipulation. In addition, the court appointed experienced law firm Grant & Eisenhofer P.A. (“Grant & Eisenhofer”) as lead counsel in the class action. According to Grant & Eisenhofer, the firm has recovered over USD $30 Billion dollars for its clients to date in some of the most complex, often precedent-setting cases, in fights against the world’s largest and richest opponents.

Advancing Precision Oncology and Partner-Ready Therapeutic Programs Through Capital-Efficient Development

The company’s flagship HCM platforms evaluated and recognized for WFM innovation

Dallas, TX, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to discuss its third quarter 2026 financial results on Thursday, November 5th, 2026 at 8:30 a.m. Eastern Time and issue an earnings press release earlier that morning. The live webcast and a presentation related to the call will be accessible from the "Investors" section of Enovis' website at www.enovis.com.

By lowering the engineering effort between an idea and the hardware, the new feature enables faster experimentation while keeping scientists in control

BOCA RATON, FL, Oct. 08, 2026 (GLOBE NEWSWIRE) -- DeFi Development Corp. (Nasdaq: DFDV) (the “Company”), the first U.S. public company with a treasury strategy built around accumulating and compounding Solana (SOL), today announced the release of its August & September 2026 Recap, highlighting renewed SOL accumulation, the launch of CHAD, continued execution of the Company’s SOL Boost strategy, and expanded engagement across the Solana ecosystem.

Platform Designed to Connect Lead Generation, CRM, Quoting, Pricing, Freight and Order Processing; Integration into GrowGen Sales Operations Planned for 2027

Fourth consecutive year Capitolis has been recognized at the Euromoney Foreign Exchange Awards

Six-month data on a new bio-reinforced canaloplasty procedure show 37% IOP reduction; new findings on bio-reinforced cyclodialysis to be presented at AAO 2026

General Fusion completes the first major technical milestone of its LM26 program with world-first fusion result co-authored by the UKAEA

New 295 nm UVB Wellness Lamp Designed Around a Wavelength Studied for Supporting the Body’s Natural Vitamin D Production

LONDON, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Today OpenFX, the cross-border payments infrastructure company whose mission is to convert, settle and move money across the globe, announced the launch of OpenFX Ventures. This is a new investment arm that will partner with early-stage founders across the U.S., Europe, Latin America, and APAC.

Published patent application covers 3-MMC-based treatment of dyskinesia, including in combination with Palmitoylethanolamide (PEA)

Guangzhou, China, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Top KingWin Ltd (NASDAQ: DPU) (the “Company”) is pleased to announce that it has changed its name to “Nexpu Ltd.” on August 31, 2026. The change of name will be effective on Nasdaq on October 9, 2026. The Company’s class A ordinary shares will continue trading on the Nasdaq Capital Market under the trading symbol “DPU”, and the CUSIP number shall remain unchanged.

Revenue grew 59% year-over-year to $16.2 million; GCC revenue more than doubled (+107%)

TORONTO, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2026 third quarter earnings conference call on Thursday, November 5, 2026, at 8:30 a.m. ET. Cronos’ senior management team will discuss the Company’s financial results and will be available for questions from the investment community after prepared remarks.

Expects to scale to 20 gigawatts by 2030 as it advances Bring Your Own Capacity™ and grows its base of connected batteries

NEW YORK and TORONTO, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Helus Pharma Inc. (Nasdaq: HELP) (Cboe CA: HELP) (“Helus” or the “Company”), a clinical-stage pharmaceutical company committed to helping minds heal by developing novel serotonergic agonists (“NSAs”), is pleased to announce that the Company will host an investor presentation on October 21, 2026.

WASHINGTON, Oct. 08, 2026 (GLOBE NEWSWIRE) -- FTI Consulting, Inc. (NYSE: FCN) today announced that it will release financial results for the third quarter ended September 30, 2026, before the New York market opens on Thursday, October 29, 2026.

COLUMBIA, S.C., Oct. 08, 2026 (GLOBE NEWSWIRE) -- The Ritedose Corporation announced the opening of its new state-of-the-art current Good Manufacturing Practice (cGMP) laboratory, marking a major milestone in the Company's continued growth and reinforcing its position as a pharmaceutical manufacturing and life sciences innovation leader. The new analytical chemistry laboratory, coupled with the expansion of Ritedose's microbiology laboratory at its main manufacturing campus, creates a unique integrated laboratory infrastructure designed to support the Company's continued manufacturing growth while providing comprehensive, in-house analytical services.

On average, Indecomm has added 70 new engagements and 36 clients per year over the past three fiscal years, with the current fiscal year on pace to match that performance

Maximizes Customer Value With More Kilowatt Hours Per Year

First-Quarter Results Reinforce Tilray’s Progress Converting Global Scale, Disciplined Execution and Category Leadership into Higher Revenue, Expanded Gross Profit and Continued Momentum

New Platform Enhancements and AI-Powered Capabilities Can Help Pest Control Operators Improve Efficiency, Strengthen Customer Experiences, and Drive Profitable Growth

GREENWICH, Conn., Oct. 08, 2026 (GLOBE NEWSWIRE) --  GXO Logistics, Inc. (NYSE: GXO) will hold its third quarter 2026 earnings conference call and webcast on Wednesday, November 4, 2026, at 8:30 a.m. Eastern Time. The company’s results will be released after market close on Tuesday, November 3, 2026, and made available at that time on investors.gxo.com.

Phase 1/2 clinical trial of EDIT-401 cleared to initiate dosing in patients who require additional LDL-C lowering 

The new partnership between Trupanion and Cowell aims to raise awareness about growing needs within the pet community

Herzliya, Israel, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Beamr Imaging Ltd. (NASDAQ: BMR), a leader in video optimization technology and solutions, today announced the Company will present at the following investor conference:

CAMBRIDGE, Mass., Oct. 08, 2026 (GLOBE NEWSWIRE) -- Cullinan Therapeutics, Inc. (Nasdaq: CGEM; “Cullinan”), a clinical-stage biopharmaceutical company accelerating potential first- or best-in-class, disease-modifying T cell engagers in autoimmune diseases and cancer, today announced that the first patient has been dosed in its pivotal Phase 2 study of CLN-049, a novel, investigational FLT3 T cell engager, in patients with relapsed/refractory acute myeloid leukemia (AML).

BROOMFIELD, Colo., Oct. 08, 2026 (GLOBE NEWSWIRE) -- Gogo (NASDAQ: GOGO) has signed a sovereign-based communications lease in excess of $15 million USD to provide geostationary (GEO) satellite connectivity to a government customer.

BETHESDA, Md., Oct. 08, 2026 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small-molecule therapies, today announced it will participate in the upcoming 2026 Maxim Growth Summit, taking place from October 12th to 14th at The Hard Rock Hotel New York, in New York City.

New Intelligence Layer Helps Contractors Identify Operational Challenges, Make Smarter Decisions, and Drive Profitable Growth

Nutriband files new non-provisional patent application to strengthen intellectual property protection of its AVERSA™ transdermal abuse deterrent technology being developed for patches containing opioids and stimulants with a potential for abuse.

Jody Kelman joins as Chief Product Officer and Emelia Probasco as Head of Strategy and Communications as Muon enters its next phase of growth

The new generation of Pulsar Max introduces ISO 15118-ready hardware designed to support evolving European AFIR charging requirements, alongside built-in RFID and Ethernet connectivity

Company ranks No. 25 nationally in Healthiest Employers® program

SHENZHEN, China, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Huize Holding Limited ("Huize" or the "Company") (NASDAQ: HUIZ), a leading insurance technology platform connecting consumers, insurance carriers and distribution partners digitally through data-driven and AI-powered solutions in Asia, today announced that Ron Tam, Co-CFO of Huize and CEO of Poni Insurtech, Huize's international arm, will present at the 20th Annual LD Micro Main Event, taking place October 19-21, 2026 at the Luxe Sunset Boulevard Hotel in Los Angeles, California.

Publicity Department of the Shenyang Municipal Party Committee

SEATTLE, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (“Perspective,” the “Company,” “we,” “us,” and “our”) (NYSE AMERICAN: CATX), a radiopharmaceutical development company pioneering advanced treatments for cancers throughout the body, today announced that the U.S. Food and Drug Administration (the “FDA”) granted Fast Track Designation for the development of PSV359 for adult patients with locally advanced unresectable and/or metastatic fibroblast activation protein (FAP)-positive solitary fibrous tumors (SFTs).